Harold Marcotte Selected Research

Metronidazole (Metric)

9/2019	An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
8/2011	Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harold Marcotte Research Topics

Disease

12	Infections 01/2024 - 12/2006
8	COVID-19 04/2024 - 12/2021
6	Bacterial Vaginosis 10/2019 - 08/2011
6	Diarrhea 01/2016 - 12/2006
3	Inflammation (Inflammations) 07/2023 - 01/2016
3	Rotavirus Infections 01/2014 - 05/2011
2	Caliciviridae Infections 12/2022 - 01/2020
2	COVID-19 related pediatric multisystem inflammatory disease 11/2022 - 01/2022
1	Breakthrough Infections 01/2024
1	Stomach Neoplasms (Stomach Cancer) 07/2023
1	Stomach Diseases 05/2023
1	Duodenal Ulcer (Curling's Ulcer) 05/2023
1	Type I Syndactyly 01/2023
1	Rhinitis 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Neoplasms (Cancer) 12/2020
1	Vaginal Discharge 09/2019
1	Dysbiosis 06/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2017
1	Colonic Neoplasms (Colon Cancer) 08/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Vulvovaginal Candidiasis 07/2015
1	Anthrax 12/2011
1	Edema (Dropsy) 12/2011
1	Dental Caries (Decay, Dental) 10/2006

Drug/Important Bio-Agent (IBA)

7	Anti-Bacterial Agents (Antibiotics)IBA 07/2023 - 08/2011
6	AntibodiesIBA 05/2023 - 09/2007
6	Immunoglobulin FragmentsIBA 01/2020 - 12/2006
5	Proteins (Proteins, Gene)FDA Link 07/2023 - 05/2011
5	Single-Domain AntibodiesIBA 12/2022 - 10/2006
4	Immunoglobulin G (IgG)IBA 01/2024 - 01/2014
3	Angiotensin-Converting Enzyme 2IBA 01/2024 - 01/2023
3	AutoantibodiesIBA 11/2022 - 01/2022
3	VaccinesIBA 02/2022 - 01/2014
3	Immunoglobulin M (IgM)IBA 01/2022 - 12/2021
2	mRNA VaccinesIBA 01/2024 - 01/2022
2	Immunoglobulin A (IgA)IBA 01/2024 - 11/2022
2	Blocking AntibodiesIBA 07/2023 - 05/2023
2	AntigensIBA 07/2023 - 12/2011
2	Therapeutic UsesIBA 10/2019 - 10/2006
2	Metronidazole (Metric)FDA LinkGeneric 09/2019 - 08/2011
2	Immunoglobulins (Immunoglobulin)IBA 01/2016 - 09/2007
1	RNA (Ribonucleic Acid)IBA 04/2024
1	ChAdOx1 nCoV-19IBA 04/2024
1	Secretory Immunoglobulin A (SIgA)IBA 01/2024
1	DXP-604IBA 01/2024
1	Neutralizing AntibodiesIBA 12/2022
1	Antiviral Agents (Antivirals)IBA 02/2022
1	Immunoglobulin E (IgE)IBA 01/2022
1	Inactivated VaccinesIBA 01/2022
1	AngiotensinsIBA 01/2022
1	Interferon Type IIBA 01/2022
1	Monoclonal AntibodiesIBA 12/2021
1	Broadly Neutralizing AntibodiesIBA 12/2020
1	Cefixime (Suprax)FDA Link 09/2019
1	Doxycycline (Periostat)FDA LinkGeneric 09/2019
1	Interleukin-22 (IL-22)IBA 08/2017
1	Interleukin-10 (Interleukin 10)IBA 08/2017
1	trimethylaminocarboxyldihydroboran (TCDB)IBA 01/2016
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2016
1	ExotoxinsIBA 01/2016
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2013
1	edema factorIBA 12/2011
1	anthrax toxin (anthrax lethal factor)IBA 12/2011
1	Clindamycin (Cleocin)FDA LinkGeneric 08/2011
1	Capsules (Microcapsules)IBA 08/2011

Therapy/Procedure

6	Therapeutics 12/2021 - 05/2011
1	Intranasal Administration 01/2024
1	Stem Cell Transplantation 08/2017